SACTSONJ
IDXX icon

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Idexx Laboratories IDXX Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$266K Sell
506
-35
-6% -$19.6K 0.07% 251
2026
Q1 		$304K Buy
+541
New +$347K 0.09% 225

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Supplemental Annuity Collective Trust (SACT) of New Jersey's IDXX Position: Q2 2026 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey reduced its Idexx Laboratories (IDXX) stake by 6.5% in Q2 2026, selling an estimated $19.6K and leaving 506 shares worth $266K. The position accounts for 0.07% of the portfolio, ranked #251.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $304K in Q1 2026. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Supplemental Annuity Collective Trust (SACT) of New Jersey held 506 shares of Idexx Laboratories worth $266K as of Q2 2026.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey sold 35 Idexx Laboratories shares in Q2 2026, an estimated $19.6K.
  • Idexx Laboratories made up 0.07% of Supplemental Annuity Collective Trust (SACT) of New Jersey's portfolio in Q2 2026, its #251 holding.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey's Idexx Laboratories position peaked at $304K in Q1 2026.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q2 2026, filed 27 Jul 2026.